Company Biography
Treatment Patterns Following Osimertinib Discontinuation in Patients with EGFR Mutated Metastatic NSCLC
Link to Abstract. A PDF of the poster is available to download under the Resources tab
Contact Information
Name
Elizabeth Marrett
You have chosen to your
information with
Treatment Patterns Following Osimertinib Discontinuation in Patients with EGFR Mutated Metastatic NSCLC
Team Members
Ameur Manceur, PhD
Analysis Group
Elizabeth Marrett, MPH
Daiichi Sankyo, Inc
Winghan Jacqueline Kwong, PhD
Daiichi Sankyo, Inc.
Jinlin Song, PhD
Analysis Group
Selvam Sendhil, BS
Analysis Group